ACS Chemical Biology · 2021 · 28 citations · 35 references
Life SciencesNeuroscienceToxicologyAutism Spectrum DisordersDevelopmental ToxicologyMetabolomicsDevelopmental NeurotoxicologyMetabolite ProfilingNeurodevelopmental DisordersNeurodevelopmental ToxicityNuclear Magnetic Resonance MetabolomicsUntargeted MetabolomicsAge-related Metabolic ChangesCholine MetabolismIn Vivo Nmr SpectroscopyNeurodevelopmental Outcomes After Prenatal ExposureNuclear Magnetic Resonance Spectroscopy-based Metabolite ProfilingPrenatal NeuropharmacologyValproic Acid
-acetylaspartate (NAA), amino acid neurotransmitters (e.g., glutamate, glutamine, GABA, glycine), pyroglutamic acid, unsaturated fatty acids, and choline-based compounds are discriminant biomarkers. Additionally, metabolic changes varied as a function of age, but importantly not of sex.
35
Jon Baio, Lisa D. Wiggins, Deborah Christensen et al. · MMWR Surveillance Summaries · 2018 · 5.5K citations · Full text
Sven Sandin, Paul Lichtenstein, Ralf Kuja‐Halkola et al. · JAMA · 2014 · 1K citations
Characteristics of fetal anticonvulsant syndrome associated autistic disorder
AD Rasalam, H. Hailey, JHG Williams et al. · Developmental Medicine & Child Neurology · 2005 · 454 citations
Medicine, Pediatrics, Psychiatry +16